In a study published in September in the journal iScience, metformin was found to have potential benefits for people living with HIV. In a 12-week pilot clinical trial involving 13 participants on antiretroviral therapy, metformin supplementation helped boost the immune system’s ability to target and contain the virus.
In a separate study, published Sept. 17 in Diabetes Care suggests metformin use before and during a COVID-19 infection can reduce the risk of severe COVID and post-acute sequelae of COVID-19. In the cohort analysis, metformin users with Type 2 diabetes saw a 21% lower risk of death or PASC compared to those using other diabetes medications.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.